TechnoPhage SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TechnoPhage SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11209
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポルトガル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TechnoPhage SA (TechnoPhage) is a biopharmaceutical company that offers contract research and development of new molecules. The company conducts its research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development services for private and public institutions and pharmaceutical companies, among others. TechnoPhage also collaborates with universities, national and international pharmaceutical companies, academic institutions, research centres and other industrial sectors. The company also operates its laboratories in the facilities of the Instituto de Medicina Molecular. TechoPhage is headquartered in Lisbon, Portugal.

TechnoPhage SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TechnoPhage SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TechnoPhage SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
TechnoPhage Enters into Agreement with Faculty of Veterinary Medicine, University of Lisbon 10
TechnoPhage Enters into Co-Development Agreement with University of Macau 11
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 12
TechnoPhage SA – Key Competitors 13
TechnoPhage SA – Key Employees 14
TechnoPhage SA – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
TechnoPhage SA, Pharmaceuticals & Healthcare, Key Facts 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TechnoPhage SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TechnoPhage SA, Deals By Therapy Area, 2012 to YTD 2018 8
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TechnoPhage Enters into Agreement with Faculty of Veterinary Medicine, University of Lisbon 10
TechnoPhage Enters into Co-Development Agreement with University of Macau 11
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 12
TechnoPhage SA, Key Competitors 13
TechnoPhage SA, Key Employees 14

List of Figures
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[TechnoPhage SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chicago Bridge & Iron Company NV (CBI):石油・ガス:M&Aディール及び事業提携情報
    Summary Chicago Bridge & Iron Company NV (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental services …
  • Cranswick plc:企業の戦略・SWOT・財務情報
    Cranswick plc - Strategy, SWOT and Corporate Finance Report Summary Cranswick plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Solaris d.d.:企業の戦略・SWOT・財務情報
    Solaris d.d. - Strategy, SWOT and Corporate Finance Report Summary Solaris d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Chart Industries Inc (GTLS):企業の財務・戦略的SWOT分析
    Chart Industries Inc (GTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pacific Textiles Holdings Ltd (1382):企業の財務・戦略的SWOT分析
    Pacific Textiles Holdings Ltd (1382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Corporation Bank:企業のM&A・事業提携・投資動向
    Corporation Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corporation Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Molex LLC:企業のM&A・事業提携・投資動向
    Molex LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molex LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Epinex Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Epinex Diagnostics Inc (Epinex Diagnostics) is a medical device company that develops rapid diagnostic tests. The company’s products include over-the-counter test device, Epinex G1A Test system, Epinex ACR Test system, Epinex SimplySure PT-INR Test system and point-of-care test device, among …
  • Aerovironment Inc:企業の戦略・SWOT・財務分析
    Aerovironment Inc - Strategy, SWOT and Corporate Finance Report Summary Aerovironment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Quaker Chemical Corp (KWR):企業の財務・戦略的SWOT分析
    Quaker Chemical Corp (KWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mission Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mission Therapeutics Ltd (Mission) is a drug discovery company that develops small molecule drugs targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company’s USP30 is the DUB that localizes to the outer mitochondrial membrane. Its USP7 is a DUB wit …
  • Lamellar Biomedical Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Lamellar Biomedical Ltd (Lamellar Biomedical) is a biotechnology company that develops medical products using based on mimetics of extra-alveolar lamellar bodies. The company develops products using its proprietary Lamellasome technology that are mimetics of native extra-alveolar lamellar th …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …
  • CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • First Light Diagnostics Inc:企業の製品パイプライン分析
    Summary First Light Diagnostics Inc (FLD) is a medical device company that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes multipath analyzer system. Its multipath analyzer system detects resistant …
  • Autoliv, Inc.:企業の戦略・SWOT・財務情報
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MAX Resource Corp. (MXR):企業の財務・戦略的SWOT分析
    MAX Resource Corp. (MXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Jardine Engineering Corporation, Limited:企業の戦略・SWOT・財務情報
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Vital Therapies Inc (VTL)-製薬・医療分野:企業M&A・提携分析
    Summary Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute l …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆